Literature DB >> 33488710

Survivin Regulates Bad Gene Expression by Binding to Its Promoter and Modulates Cell Cycle and Apoptosis in Esophageal Carcinoma Cell.

Yan Chen1, Shayahati Bieerkehazhi1, Xiumei Li2, Lili Ma3, Waresijiang Yibulayin4, Jihua Ran5.   

Abstract

Esophageal cancer (EC) is the eighth most prevalent cancer and the sixth leading cause of cancer-related mortality worldwide. As an antiapoptotic and a proapoptotic protein, respectively, survivin and Bad play an important role in carcinogenesis of the most human cancers including EC. However, the regulatory relationships between them remain unclear. We sought to investigate the effects of survivin knockdown and overexpression on the expression of Bad gene, cell cycle progression, and apoptosis of esophageal carcinoma cell. The mRNA expression levels of survivin and Bad were determined in EC tissue samples. The knockdown and overexpression experiments were performed in ECA109 and KYSE450 cells via transfection with survivin overexpression and shRNA plasmids. A Bad overexpression experiment was conducted to confirm the biological effect on knockdown of survivin via modulating Bad expression. RT-qPCR and Western blot analysis were used to detect mRNA and protein expression, respectively. Cell cycle and apoptosis were analyzed by flow cytometry. The chromatin immunoprecipitation (ChIP) was conducted to determine the binding sites of survivin on the promoter of Bad gene. By analyzing the mRNA expression of survivin and Bad in 40 ESCC patient specimens, we found that the positive expression rate of survivin in tumor tissues (88%, 35/40) was remarkably high, compared with the distal nontumor tissues (48%, 19/40, p < 0.01). On the other hand, the positive expression rate of Bad in tumor tissues (70%, 28/40) was remarkably low, compared with the distal nontumor tissues (95%, 38/40, p < 0.01). Overexpression of survivin decreases Bad mRNA and protein expression and promotes transformation of cell cycle to S phase. Conversely, knockdown of survivin increases Bad mRNA and protein expression and induces cell cycle arrest and apoptosis. Bad overexpression inducing apoptosis of esophageal carcinoma cell shows the similar apoptotic effect with survivin knockdown. ChIP assays indicate that survivin directly binds to the Bad promoter region, diminishing the transcriptional activity of Bad. In conclusion, the result suggested that survivin regulates Bad gene expression by binding to its promoter and modulates cell cycle and apoptosis in esophageal carcinoma cell.
Copyright © 2021 Yan Chen et al.

Entities:  

Year:  2021        PMID: 33488710      PMCID: PMC7803392          DOI: 10.1155/2021/1384289

Source DB:  PubMed          Journal:  J Oncol        ISSN: 1687-8450            Impact factor:   4.375


  15 in total

Review 1.  Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.

Authors:  Peter E Czabotar; Guillaume Lessene; Andreas Strasser; Jerry M Adams
Journal:  Nat Rev Mol Cell Biol       Date:  2014-01       Impact factor: 94.444

2.  Esophageal carcinoma.

Authors:  Anil K Rustgi; Hashem B El-Serag
Journal:  N Engl J Med       Date:  2014-12-25       Impact factor: 91.245

3.  Loss of Bad expression confers poor prognosis in non-small cell lung cancer.

Authors:  Yi Huang; Dan Liu; Bojiang Chen; Jing Zeng; Lei Wang; Shangfu Zhang; Xianming Mo; Weimin Li
Journal:  Med Oncol       Date:  2011-09-15       Impact factor: 3.064

Review 4.  Survivin as a novel target protein for reducing the proliferation of cancer cells.

Authors:  Dongyu Li; Chenghao Hu; Huibin Li
Journal:  Biomed Rep       Date:  2018-03-13

5.  BCL-2 family protein, BAD is down-regulated in breast cancer and inhibits cell invasion.

Authors:  Maria Cekanova; Romaine I Fernando; Nalin Siriwardhana; Mugdha Sukhthankar; Columba de la Parra; Jirayus Woraratphoka; Christine Malone; Anders Ström; Seung J Baek; Paul A Wade; Arnold M Saxton; Robert M Donnell; Richard G Pestell; Suranganie Dharmawardhane; Jay Wimalasena
Journal:  Exp Cell Res       Date:  2014-12-09       Impact factor: 3.905

6.  Clinicopathological and prognostic significance of survivin over-expression in patients with esophageal squamous cell carcinoma: a meta-analysis.

Authors:  Chunguang Li; Zhigang Li; Maoling Zhu; Tiejun Zhao; Ling Chen; Weidan Ji; Hezhong Chen; Changqing Su
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

7.  Survivin activates NF‑κB p65 via the IKKβ promoter in esophageal squamous cell carcinoma.

Authors:  Wei Zeng; Hui Li; Yan Chen; Hongbo Lv; Ling Liu; Jihua Ran; Xiaohong Sun; Shayahati Bieerkehazhi; Yining Liu; Xiaomiao Li; Wenting Lai; Jibieke Watibieke; Meiliwuerti Dawulietihan; Xiumei Li; Huiwu Li
Journal:  Mol Med Rep       Date:  2015-12-30       Impact factor: 3.423

Review 8.  Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies.

Authors:  Xun Chen; Ning Duan; Caiguo Zhang; Wentao Zhang
Journal:  J Cancer       Date:  2016-01-10       Impact factor: 4.207

Review 9.  Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma.

Authors:  Zakir Khan; Abdul Arif Khan; Hariom Yadav; Godavarthi B K S Prasad; Prakash Singh Bisen
Journal:  Cell Mol Biol Lett       Date:  2017-04-05       Impact factor: 5.787

Review 10.  Targeting BCL-2 regulated apoptosis in cancer.

Authors:  Kirsteen J Campbell; Stephen W G Tait
Journal:  Open Biol       Date:  2018-05       Impact factor: 6.411

View more
  1 in total

1.  Sporoderm-Removed Ganoderma lucidum Spore Powder May Suppress the Proliferation, Migration, and Invasion of Esophageal Squamous Cell Carcinoma Cells Through PI3K/AKT/mTOR and Erk Pathway.

Authors:  Guiping Liu; Tao Zeng
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.